DNMT1 and breast carcinoma: Similarly, Al-Kharashi et al. observed that decitabine and eugenol downregulated DNMT1 and DNMT3A through E2F1-mediated pathway [255], which blocked VEGF-A and IL-8 secretion and reversed the pro-angiogenic phenotype of CAFs in breast cancer [257].